Ask AI
ProCE Banner Activity

Advances in ART Podcast: Putting New Data on Emerging Options in Context

Podcast Episodes

Listen now as experts, Chloe Orkin, MBChB, FRCP, MD, and Jihad Slim, MD, explore the potential clinical implications of new data on novel options for optimizing HIV therapy, especially for treatment-experienced people with challenges using currently available regimens, high pill burdens, and reduced adherence. Listen on the go or follow along with our expert-curated slides

Released: May 11, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education in partnership with American Academy of HIV Medicine, Association of Nurses in AIDS Care (ANAC), and HealthHIV.

ProCE Banner

Supporters

Supported by an educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.

Partners

American Academy of HIV Medicine

ProCE Banner

ANAC

ProCE Banner

HealthHIV

ProCE Banner

Target Audience

This activity is intended for physicians, pharmacists, registered nurses, and advanced practice professionals who provide HIV care in specialist or primary care settings.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Integrate data on newer and emerging options for HIV care into management strategies

  • Adopt strategies for the use of ART that align with new evidence and guideline recommendations

Disclosure

Primary Author

Chloe Orkin, MBChB, FRCP, MD: consultant/advisor/speaker: Gilead, GSK, Merck Sharp & Dohme, ViiV.

Jihad Slim, MD: consultant/advisor/speaker: AbbVie, Gilead, Merck, ViiV.